Press Release
Aiforia obtained the In Vitro Diagnostic Regulation (IVDR) certification and successfully launches three new CE-IVD marked AI solutions for breast and prostate cancer diagnostics Aiforia Technologies Plc, Press Release, February 20, 2025 at...
WILMINGTON, Mass. and DUBLIN, Ireland—February 10, 2025—Charles River Laboratories International, Inc. (NYSE: CRL) and Deciphex, a leader in AI-powered digital pathology, today announced the next phase of a strategic collaboration to focus...
Harrison.ai: Company’s Radiology and Pathology Solutions Expand Clinician Capacity, Increase Operational Efficiency, and Improve Early Disease Diagnosis February 11, 2025 10:00 AM Eastern Standard Time BOSTON--(BUSINESS...
Ibex: FDA clearance affirms Ibex’s position as a global leader in AI-powered cancer diagnostics February 10, 2025 08:05 AM Eastern Standard Time BOSTON--(BUSINESS WIRE)--Ibex Medical Analytics (Ibex), the leader in...
Nijmegen, the Netherlands – Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has announced the latest advancement in its automated quality control (QC)...
Nijmegen, the Netherlands – Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, is thrilled to announce the integration of its NephroPath AI tools into HistoWiz’s PathologyMap™ platform....
